May 1, 2020
VIA EDGAR
Division of Corporation Finance
Office of Life Sciences
United States Securities and Exchange Commission
100 F Street, NE
Washington, D.C. 20549
Attention: Jeffrey Gabor
|
Re: |
Cassava Sciences, Inc. |
|
|
Registration Statement on Form S-3 |
|
|
File No. 333-237452 |
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Cassava Sciences, Inc. (the “Registrant”) hereby requests acceleration of effectiveness of its registration statement on Form S-3 (File No. 333-237452) to 4:00 p.m., Eastern Time, on May 5, 2020, or as soon as practicable thereafter.
The Registrant requests that it be notified of such effectiveness by contacting Alfredo B. D. Silva, the Company’s counsel at Morrison & Foerster LLP, at (415) 268-6213 or asilva@mofo.com.
|
|
Very truly yours, |
|
|
|
|
|
|
|
Cassava Sciences, Inc. |
|
|
|
|
|
|
|
By: |
/s/ Remi Barbier |
|
|
Name: |
Remi Barbier |
|
|
Title: |
Chief Executive Officer |